(R)-1-(6-Bromopyridin-2-yl)ethan-1-ol

Catalog No. :
ACTAXR306
CAS No. :
138983-04-7
Molecular Formula :
C7H8BrNO
Molecular Weight :
202.05

IUPAC Name:(R)-1-(6-bromopyridin-2-yl)ethan-1-ol

(R)-1-(6-Bromopyridin-2-yl)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$69.00Login to see priceIn stockInquiry
100mg95%$100.00Login to see priceIn stockInquiry
250mg95%$164.00Login to see priceIn stockInquiry
1g95%$466.00Login to see priceIn stockInquiry
5g95%$1821.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(6-Bromopyridin-2-yl)ethan-1-ol
IUPAC Name(R)-1-(6-bromopyridin-2-yl)ethan-1-ol
MDL No.MFCD22570003
Molecular FormulaC7H8BrNO
Molecular Weight202.05
SMILESC[C@H](C1=NC(Br)=CC=C1)O
InChI KeyWOLKOZYBCJFJCM-RXMQYKEDSA-N
Synonym2-fluoro-2H-phosphirene;(R)-(+)-2-(1-hydroxyethyl)-6-bromopyridine;(R)-1-(6-Bromopyridin-2-yl)ethan-1-ol;2-Pyridinemethanol, 6-bromo-α-methyl-, (αR)-;(1R)-1-(6-Bromopyridin-2-yl)ethan-1-ol;(R)-1-(6-Bromopyridin-2-yl)ethan-1-ol - [B90695]
CAS No.138983-04-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACTAXR306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHLS124 route compound structure diagram
    ACEHLS12449669-13-8 In Stock
  2. Then
  3. ACTAXR306 route product structure diagram
    ACTAXR306138983-04-7 In Stock
Inquiry

2. ACTAXR306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRJIX213 route compound structure diagram
    ACRJIX21334160-40-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTAXR306 route product structure diagram
    ACTAXR306138983-04-7 In Stock
Inquiry

Comments (0)